Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
CAPS Rating:
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
RSS Headlines
Fool UK
Recs
Very strong pipeline, with some exciting results due out at the end of this year.